Facilitating Drug Discovery and Development with Mechanistic Physiological Models that are "Fit for Purpose": Introducing a Model Qualification Method.
暂无分享,去创建一个
[1] K. S. Brown,et al. Statistical mechanical approaches to models with many poorly known parameters. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.
[2] Marc Pfister,et al. Model‐Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry , 2010, Journal of clinical pharmacology.
[3] N Le Novère,et al. SysBioMed report: advancing systems biology for medical applications. , 2009, IET systems biology.
[4] Ben van Ommen,et al. Nutritional Systems Biology Modeling: From Molecular Mechanisms to Physiology , 2009, PLoS Comput. Biol..
[5] Michael J Joyner,et al. Ten questions about systems biology , 2011, The Journal of physiology.
[6] Zvia Agur,et al. Use of Virtual Patient Populations for Rescuing Discontinued Drug Candidates and for Reducing the Number of Patients in Clinical Trials , 2009, Alternatives to laboratory animals : ATLA.
[7] Jogarao V. S. Gobburu,et al. A new equivalence based metric for predictive check to qualify mixed-effects models , 2005, The AAPS Journal.
[8] Natal A. W. van Riel,et al. Dynamic modelling and analysis of biochemical networks: mechanism-based models and model-based experiments , 2006, Briefings Bioinform..
[9] J. Rullmann,et al. Systems biology for battling rheumatoid arthritis: application of the Entelos PhysioLab platform. , 2005, Systems biology.
[10] Pamela K. Kreeger,et al. Cancer systems biology: a network modeling perspective , 2009, Carcinogenesis.
[11] Nicholas H. G. Holford,et al. The Visual Predictive Check Superiority to Standard Diagnostic (Rorschach) Plots , 2005 .
[12] Y. Lazebnik. Can a biologist fix a radio? -- Or, what I learned while studying apoptosis, (Cancer Cell. 2002 Sep;2(3):179-82). , 2002, Biochemistry. Biokhimiia.
[13] David S Wishart,et al. Computational systems biology in drug discovery and development: methods and applications. , 2007, Drug discovery today.
[14] Ping Zhang,et al. Guidelines for computer modeling of diabetes and its complications , 2004 .
[15] Hiroaki Kitano,et al. Next generation simulation tools: the Systems Biology Workbench and BioSPICE integration. , 2003, Omics : a journal of integrative biology.
[16] Ton Rullmann,et al. Target validation in silico: does the virtual patient cure the pharma pipeline? , 2006, Expert opinion on therapeutic targets.
[17] Danny Petrasek. Systems Biology: The Case for a Systems Science Approach to Diabetes , 2008, Journal of diabetes science and technology.
[18] E. Kunkel. Systems biology in drug discovery , 2004, Nature Biotechnology.
[19] Daniel A. Beard,et al. Strong Inference for Systems Biology , 2009, PLoS Comput. Biol..
[20] U. Bhalla,et al. Systems modeling: a pathway to drug discovery. , 2005, Current opinion in chemical biology.
[21] Christina Maria Friedrich,et al. In silico predictions of target clinical efficacy , 2004 .
[22] Christopher R Myers,et al. Extracting Falsifiable Predictions from Sloppy Models , 2007, Annals of the New York Academy of Sciences.
[23] K Gadkar,et al. The Type 1 Diabetes PhysioLab® Platform: a validated physiologically based mathematical model of pathogenesis in the non‐obese diabetic mouse , 2010, Clinical and experimental immunology.
[24] Richard H. Middleton,et al. Quantifying uncertainty, variability and likelihood for ordinary differential equation models , 2010, BMC Systems Biology.
[25] Christopher R. Myers,et al. Universally Sloppy Parameter Sensitivities in Systems Biology Models , 2007, PLoS Comput. Biol..
[26] Daniel A Beard,et al. Computational modeling of physiological systems. , 2005, Physiological genomics.
[27] Seth Michelson,et al. Chapter 27. Biosimulation: Dynamic modeling of biological systems , 2002 .
[28] Michael Kohl,et al. Standards, databases, and modeling tools in systems biology. , 2011, Methods in molecular biology.
[29] K. S. Brown,et al. Sloppy-model universality class and the Vandermonde matrix. , 2006, Physical review letters.
[30] J. Doyle,et al. Reverse Engineering of Biological Complexity , 2002, Science.
[31] Neil Benson,et al. Systems Pharmacology: Bridging Systems Biology and Pharmacokinetics-Pharmacodynamics (PKPD) in Drug Discovery and Development , 2011, Pharmaceutical Research.
[32] D. Lauffenburger,et al. Applying computational modeling to drug discovery and development. , 2006, Drug discovery today.
[33] D. Kirschner,et al. A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.
[34] Matthias von Herrath,et al. Virtual Optimization of Nasal Insulin Therapy Predicts Immunization Frequency to Be Crucial for Diabetes Protection , 2010, Diabetes.